More On:
opioids
NYC sues consulting firm for role in opioid crisis
Pharma execs called West Virginians ‘pillbillies’ during opioid crisis
A city wrestled down an addiction crisis — then came COVID-19
$1M in fentanyl pills found inside 6-year-old’s car seat
New York Attorney General Letitia James announced a $230 million settlement with Johnson & Johnson Saturday morning, resolving claims regarding the company’s “role in helping to fuel the opioid epidemic,” according to a press release.
“The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids,” James said in a statement.
“Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business — not only in New York, but across the entire country.”
The money, to be paid to the state over nine years, will be spent “to prevent any future devastation” from opioids.
“Today’s agreement also makes enforceable a bar stopping J&J and all of its subsidiaries, predecessors, and successors from manufacturing or selling opioids anywhere in New York, and acknowledges Johnson & Johnson’s exit from the opioid business nationally,” according to the press release.
The attorney general’s office sued numerous opioid manufacturers and distributors in 2019; the trial against several of them is scheduled to begin next week.
J&J said the settlement was not an admission of wrongdoing in a Saturday-morning statement.
Share this article:
Source: Read Full Article
